BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shekhawat J, Gauba K, Gupta S, Purohit P, Mitra P, Garg M, Misra S, Sharma P, Banerjee M. Interleukin-6 Perpetrator of the COVID-19 Cytokine Storm. Indian J Clin Biochem 2021;:1-11. [PMID: 34177139 DOI: 10.1007/s12291-021-00989-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Balestra C, Lambrechts K, Mrakic-Sposta S, Vezzoli A, Levenez M, Germonpré P, Virgili F, Bosco G, Lafère P. Hypoxic and Hyperoxic Breathing as a Complement to Low-Intensity Physical Exercise Programs: A Proof-of-Principle Study. Int J Mol Sci 2021;22:9600. [PMID: 34502508 DOI: 10.3390/ijms22179600] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Sen A, Nigam A, Vachher M. Role of Polypeptide Inflammatory Biomarkers in the Diagnosis and Monitoring of COVID-19. Int J Pept Res Ther 2022;28. [DOI: 10.1007/s10989-022-10366-5] [Reference Citation Analysis]
3 Masotti L, Landini G, Panigada G, Grifoni E, Tarquini R, Cei F, Maria Angela Cimolato B, Vannucchi V, Di Pietro M, Piani F, Fortini A, Faraone A, Nenci G, Cipollini F, Blanc P, Lotti P, Di Natale M, Risaliti F, Aquilini D, Seravalle C, Bribani A, Farsi A, Micheletti I, Cioni E, Pelagalli G, Mattaliano C, Pinto G, Maria Madonia E, Sivieri I, Mannini M, Valoriani A, Brancati S, Rosselli M, Pavone E, Chiara Burla M, Sergi A. PREDICTORS OF POOR OUTCOME IN TOCILIZUMAB TREATED PATIENTS WITH SARS-CoV-2 RELATED SEVERE RESPIRATORY FAILURE: A MULTICENTRE REAL WORLD STUDY. International Immunopharmacology 2022. [DOI: 10.1016/j.intimp.2022.108709] [Reference Citation Analysis]
4 Marino A, Munafò A, Augello E, Bellanca CM, Bonomo C, Ceccarelli M, Musso N, Cantarella G, Cacopardo B, Bernardini R. Sarilumab Administration in COVID-19 Patients: Literature Review and Considerations. Infectious Disease Reports 2022;14:360-71. [DOI: 10.3390/idr14030040] [Reference Citation Analysis]